[1]
Gordan, H., Beyranvand , M.R. , Sheibani , M. , Asadpur Piranfar , M. and Pourhoseingholi, M.A. 2020. Cost Effectiveness of Rivaroxaban versus Warfarin to Prevent Stroke in Iranian AF Patients. School of Medicine Students’ Journal. 2, 3 (Sep. 2020), 18–24. DOI:https://doi.org/10.22037/smsj.v2i3.31619.